Arca Biopharma sell StockNews.com
Start price
25.03.23
/
50%
€1.84
Target price
25.03.24
-
Performance (%)
-14.49%
End price
26.03.24
€1.57
Summary
This prediction ended on 26.03.24 with a price of €1.57. The prediction for Arca Biopharma closed with a convincing performance of -14.49%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arca Biopharma | - | - | - | - |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% | 53.612% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% | 72.782% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% | 62.432% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% | 60.744% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten